Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 16Plasma cell 2Thoracic 1Other hematologic neoplasm 1Lymphoid 1Gynecologic 1Genitourinary 1CNS 1

Conditions

Multiple Myeloma 3Venous Thromboembolism 2Pulmonary Embolism 1Lymphoma 1Leukemia 1Hematologic Neoplasms 1

Interventions

apixaban 4Rivaroxaban 2enoxaparin sodium 1Tinzaparin 1Observation 1Heparin, Low-Molecular-Weight 1Enoxaparin 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Venous Thromboembolism × Rivaroxaban × Plasma cell × Clear all
NCT07270263 2025-12-26

HEM-DOAC

Medical University of Gdansk

Phase NA Recruiting
100 enrolled
Classical hematologyLymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Multiple Myeloma, Pulmonary Embolism, Hematologic Neoplasms, Venous Thromboembolism

NCT06580223 2025-07-18

Aspirin or Rivaroxaban Thromboprophylaxis for Patients With Multiple Myeloma

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase 3 Not yet recruiting
530 enrolled
Classical hematologyPlasma cell

Multiple Myeloma, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡